On Invalid Date, Biora Therapeutics (NASDAQ: BIOR) reported Q4 2023 earnings per share (EPS) of $0.67, up 139.41% year over year. Total Biora Therapeutics earnings for the quarter were -$15.41 million. In the same quarter last year, Biora Therapeutics's earnings per share (EPS) was -$1.70.
As of Q2 2024, Biora Therapeutics's earnings has grown year over year. Biora Therapeutics's earnings in the past year totalled -$124.12 million.
What is BIOR's earnings date?
Biora Therapeutics's earnings date is Invalid Date. Add BIOR to your watchlist to be reminded of BIOR's next earnings announcement.
What was BIOR's revenue last quarter?
On Invalid Date, Biora Therapeutics (NASDAQ: BIOR) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Biora Therapeutics's revenue was $14.00 thousand.
What was BIOR's revenue growth in the past year?
As of Q2 2024, Biora Therapeutics's revenue has grown -98.69% year over year. This is 247.66 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Biora Therapeutics's revenue in the past year totalled $4.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.